Method for Prevention and Treatment of Streptococcus Parauberis Infections
AssigneeIntron Biotechnology, Inc.
InventorsSeong Jun Yoon, Soo Youn Jun, An Sung Kwon, Young Jae Hur, Jung Mi Kim, Sang Hyeon Kang
Life of this patent
Estimating the term…
Abstract
A composition includes an isolated bacteriophage Str-PAP-1 having the ability to kill Streptococcus parauberis cells specifically by infecting the same, and may be used to prevent and treat Streptococcus parauberis infections. The bacteriophage Str-PAP-1 that is an active ingredient of the composition has the ability to kill Streptococcus parauberis cells and characteristically has the genome represented by nucleotide sequence of SEQ. ID. NO: 1.
Claims15
An isolated bacteriophage Str-PAP-1 having the genome represented by nucleotide sequence of SEQ. ID. NO:
- 1 that is able to kill specifically Streptococcus parauberis cells or its variants.
A composition for preventing and treating Streptococcus parauberis infections comprising an isolated bacteriophage Str-PAP-1 having the genome represented by nucleotide sequence of SEQ. ID. NO:
- 1 and also having the ability to kill Streptococcus parauberis cells or its variants as an active ingredient.
A bacteriophage Str-PAP-1 variant comprising nucleotide sequence having at least 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% sequence identity to the nucleotide sequence of SEQ. ID. NO:
- 1 that is able to kill specifically Streptococcus parauberis cells or its variants.
A composition for preventing and treating Streptococcus parauberis infections comprising an bacteriophage Str-PAP-1 variant comprising nucleotide sequence having at least 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% sequence identity to the nucleotide sequence of SEQ. ID. NO:
- 1 and also having the ability to kill Streptococcus parauberis cells or its variants as an active ingredient.
Dependencies are inferred from the claim text.